Abstract <p>A.M. Pivovarov, Ph.D., co-author of domestic preparations of recombinant human erythropoietin “Epocrin” and “Eralfon,” preparations of natural and recombinant interferon-a (“Interlock,” “Reaferon”), recombinant epidermal growth factor, and many enzyme immunoassay systems for human cytokines, gives his comments on the series of A.P. Kozlov’s articles. He notes that the discovery in the laboratory of A.P. Kozlov and co-authors of a whole class of genes with a wide tumor-specific expression makes it possible to develop therapeutic MCAs with a wide antitumor spectrum of action. Thus, the study of proteins encoded by <i>TSEEN</i> genes may become a new field of medical biotechnology, claiming to be universal.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Comments on the Series of A.P. Kozlov’s Articles “The Theory of the Evolutionary Role of Inheritable Tumors (Carcino-Evo-Devo): History of Development and Current State” in Four Parts, Published in the Journal Uspekhi Sovremennoi Biologii in 2024

  • A. M. Pivovarov

摘要

Abstract

A.M. Pivovarov, Ph.D., co-author of domestic preparations of recombinant human erythropoietin “Epocrin” and “Eralfon,” preparations of natural and recombinant interferon-a (“Interlock,” “Reaferon”), recombinant epidermal growth factor, and many enzyme immunoassay systems for human cytokines, gives his comments on the series of A.P. Kozlov’s articles. He notes that the discovery in the laboratory of A.P. Kozlov and co-authors of a whole class of genes with a wide tumor-specific expression makes it possible to develop therapeutic MCAs with a wide antitumor spectrum of action. Thus, the study of proteins encoded by TSEEN genes may become a new field of medical biotechnology, claiming to be universal.